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Enteroviral infections have been associated with the development of type 1 diabetes (T1D), a chronic
inflammatory disease characterized by autoimmune destruction of insulin-producing pancreatic beta
cells. Cultured human islets, including the insulin-producing beta cells, can be infected with cox-
sackievirus B4 (CVB4) and thus are useful for understanding cellular responses to infection. We
performed quantitative mass spectrometry analysis on cultured primary human islets infected with
CVB4 to identify molecules and pathways altered upon infection. Corresponding uninfected controls
were included in the study for comparative protein expression analyses. Proteins were significantly and
differentially regulated in human islets challenged with virus compared with their uninfected coun-
terparts. Complementary analyses of gene transcripts in CVB4-infected primary islets over a time
course validated the induction of RNA transcripts for many of the proteins that were increased in the
proteomics studies. Notably, infection with CVB4 results in a considerable decrease in insulin. Genes/
proteins modulated during CVB4 infection also include those involved in activation of immune re-
sponses, including type I interferon pathways linked to T1D pathogenesis andwith antiviral, cell repair,
and inflammatory properties. Our study applies proteomics analyses to cultured human islets chal-
lenged with virus and identifies target proteins that could be useful in T1D interventions.
Copyright © 2017 Endocrine Society
This article has been published under the terms of the Creative Commons Attribution Non-
Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-
nd/4.0/).
Freeform/Key Words: coxsackievirus, immune response, inflammation, innate immunity,
insulin, mass spectrometry, pancreatic islets, proteomics, type 1 diabetes
The pathogenesis of type 1 diabetes (T1D) is characterized by immune-mediated damage of
insulin-producing beta cells of pancreatic islets. Clinical reports and epidemiological data
support that enteroviral infections may accelerate the autoimmune disease process (see
Hyo¨ty [1] for review). Pancreatic tissue from patients with recent-onset T1D reveals en-
teroviral RNA sequences and evidence of viral proteins in islets, consistent with the possi-
bility that low-grade infection in pancreatic islets may contribute to disease progression [2],
Abbreviations: ATP6AP1, V-type proton ATPase subunit S1; CVB, coxsackievirus B; CXCR, chemokine (CXC motif) receptor; ER,
endoplasmic reticulum; hpi, hours postinfection;HIC1, hypermethylated in cancer 1 protein; IFN, interferon; IPA, Ingenuity Pathway
Analysis; ISG, interferon-stimulated gene; MAPK, mitogen-activated protein kinase; MHC, major histocompatibility complex; MOI,
multiplicity of infection; MS, mass spectrometry; poly I:C, polyinosinic-polycytidylic acid; REG3A, regenerating islet-derived protein
3-a; T1D, type 1 diabetes.
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which is of interest given implications on prevention strategies for T1D. In addition, en-
teroviral infections, including those with coxsackievirus B (CVB), have been associated
infrequently with fulminant T1D, characterized by rapid onset of insulin-deficient hyper-
glycemia and linked to a strong inflammatory immune response that preferentially destroys
beta cells [3, 4]. In such circumstances, viral infection likely plays a more direct etiologic role
toward disease.
Cultured primary human islets provide a platform for studying enteroviral replication and
host responses in a controlled experimental setting. Cytotoxic effects can be observed by mi-
croscopy, and beta cell function and innate immune responses can be evaluated in RNA and
protein harvested from islets. Previous studies reveal permissiveness of human islets to in-
fection with various enteroviruses, including poliovirus, coxsackievirus A, CVB, and echovirus
[5–11]. Following enterovirus infection of cultured primary human islets, beta cells exhibit
defects in glucose-stimulated insulin secretion [6, 7]. Viral replication efficiency, cytotoxicity,
and beta cell tropism may all contribute to virus-induced beta cell dysfunction, but the
mechanisms of insulin suppression following infection are incompletely understood.
Cytokine production and gene expression changes in infected primary human islets
provide insights into the diabetogenic potential of viruses. Infection of cultured primary
human islets with CVB4 induces type I interferon (IFN) production [12], and gene expression
studies with CVB-infected islets show induction of CXCL10 and other IFN-stimulated genes
(ISGs) [8, 13, 14]. ISGs are considerably enhanced in insulitic islets from living donors with
recent-onset T1D [15]. Notably, initial infection or repeat infection could establish a setting
for more chronic immune-mediated damage over time. Identifying markers of CVB4 infection
in islets, including specific IFN signatures, could be useful for developing new diagnostic,
treatment, or prevention options (see review by Jean-Baptiste et al. [16]).
Although such immune responses have been characterized in whole islets, defining the
contributions of individual cell types to the overall response is difficult. Understanding both
genes involved in the antiviral response and cell types thatmediate responses could provide
insights into autoimmunity directed at beta cells. Newly available sources of human beta
cells mitigate some limitations of cultured primary human islets such as limited availability
and variability in donor genetics. The EndoC-bH1 cell line, an immortalized clonal human
beta cell line, is an experimental model that provides the advantage of monotypic insulin-
producing beta cells [17] and eliminates the paracrine effects of other cell types during
infection. Because EndoC-bH1 cells are a homogenous population, they can help define cell-
intrinsic effects of virus on human beta cell gene expression and function.
The primary objective of our study was to characterize protein modulation in cultured
primary human islets following challenge with CVB4 strain JVB, with the goal of identifying
proteins and pathways that may play a role in the etiology of T1D. We selected this strain
given our previous findings in diabetes models with human islets [18]. We examined specific
gene expression changes in cultured primary human islets following CVB4 infection over a
time course for comparison with proteomics findings. To define the specific impact of CVB4 in
human beta cells, we also evaluated gene expression changes in EndoC-bH1 cells during
infection. In all cases, we found decreases in insulin following CVB4 but not in uninfected
controls. We identify additional genes/proteins modulated during CVB4 infection that may
participate in T1D pathogenesis.
1. Materials and Methods
A. Virus and Stimulants
CVB4 strain JVB (American Type Culture Collection, Manassas, VA) was propagated in
HeLa cells, and purified using a 30% sucrose cushion [19]. CVB3–enhanced green fluorescent
protein was a gift from J. L. Whitton [20]. For some experiments, cells were challenged with
polyinosinic-polycytidylic acid (poly I:C) at 100 mg/mL (InvivoGen, San Diego, CA) with
Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA).
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B. Human Islets
Primary human islets from adult donors without diabetes were obtained from Prodo Lab-
oratories, Inc. (Aliso Viejo, CA) and used according to protocols approved by the Institutional
Review Board of the University of Massachusetts Medical School. A total of 150 to 200 islet
equivalents was cultured in CMRL-1066 media (Thermo Fisher Scientific) supplemented
with 10% fetal bovine serum, L-glutamine, and penicillin/streptomycin. Cultured islets were
infected with 1 3 106 plaque-forming units of CVB/100 islet equivalents by incubating islets
in aminimal volume ofmedia at 37°C for 1 hour.Mock-infected islets were treatedwithmedia
alone. Complete medium was added, and cells were cultured at 37°C in 5% CO2.
C. EndoC-bH1 Cells
EndoC-bH1 cells (gift fromDr. R. Scharfmann) were cultured as described [17]. Virus was added
to cells at a multiplicity of infection (MOI) of 10 for 1 hour in a minimal volume to allow for
adsorption. Cells were washed with phosphate-buffered saline, and fresh medium was added.
D. Microscopy and Immunofluorescence
EndoC-bH1 cells were cultured on coverslips and infectedwith CVB4 (MOI of 10) for 24 hours.
Cells were fixed with 4% paraformaldehyde for 30 min at room temperature. See Supple-
mental Materials and Methods for details on wide-field microscopy and staining.
E. Flow Cytometry
EndoC-bH1 cells were trypsinized to obtain a single-cell suspension at the indicated time
points. Dead cells were stained using LIVE/DEAD™ Fixable Blue Stain (1:1000; Invitrogen,
Carlsbad, CA) for 20minutes. Cells were fixed and permeabilized using BDCytofix/Cytoperm
reagents (BD Biosciences, San Jose, CA) and then stained with mouse antibody to VP1, clone
5-D8/1 (1:1000 of 71mg/L; catalog numberM7064, RRID:AB_2118128; DakoCytomation) and
Alexa Fluor 488 goat antibody to mouse immunoglobulin G (1:1000; catalog number A-11029,
RRID:AB_2534088; Thermo Fisher Scientific). Flow cytometry was performed with an LSRII
(BD Biosciences) equipped with Trigon and Blue 488-nm lasers running BD FACS Diva
software (version 8.0.1; BDBiosciences) and analyzed using FlowJo (version 10.1r5; Tree Star).
F. Extraction and Processing of Proteins for Mass Spectrometry
Cultured mock-treated and CVB4-infected primary human islets from adult donors without
diabetes and EndoC-bH1 cells were harvested and washed three times with phosphate-
buffered saline to remove residual fetal bovine serum and other potential contaminants from
the culture medium. Pelleted cells were solubilized in 50% trifluoroethanol in 50 mM triethyl
ammonium bicarbonate and sonicated as described [21]. The liquid chromatography-tandem
mass spectrometry (MS) methods are listed in the Supplemental Materials and Methods.
G. Bioinformatic Analysis of Differentially Expressed Proteins
We used Ingenuity Pathway Analysis (IPA; see Ingenuity Systems, http://www.ingenuity.
com; and Qiagen, https://www.qiagenbioinformatics.com/products/ingenuity-pathway-
analysis/) to characterize the molecular functions of differentially expressed proteins
between the mock- and CVB4-infected islets and EndoC-bH1 cells.
H. Gene Expression Profiling
TRIzol reagent (Thermo Fisher Scientific) was added to cells for total RNA extraction. We
used NanoString (NanoString Technologies, Inc., Seattle, WA) CodeSets containing probes
for 123 genes, including 7 housekeeping genes (ACTB, G6PD, GAPDH, GUSB, HPRT1,
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PPP1CA, and TUBB) and CVB as previously described [18]. A total of 100 ng RNA was
hybridized, processed per themanufacturer’s procedure, and analyzed on annCounterDigital
analyzer. Datawere normalized using theNanoStringNormRpackage. Replicate values from
each experiment were averaged and used for downstream analysis. Heat maps reflect the
gene expression patterns of genes with at least twofold change by either CVB or poly I:C
compared with mock-treated samples. K-means clustering was performed on the data.
2. Results
A. CVB4 Infection of Primary Human Islets Activates Specific Cellular and Molecular
Pathways in Protein Expression Profiles
We challenged islets from three independent human donors (see Supplemental Table 1 for
details) with CVB4 and compared them to uninfected islets by MS at 48 hours postinfection
(hpi), a time point previously used to examine changes in gene expression in CVB4-infected
human islets [18]. Using software algorithms to identify and quantify differential protein
expression, we identified .2000 proteins, of which 55 proteins were significantly differen-
tially regulated in at least two of the three donors. In addition to viral proteins that constitute
the CVB4 polyprotein (CXB4 in Table 1), 36 host proteins were significantly upregulated and
19 were significantly downregulated in the infected islets compared with the mock-infected
controls. Table 1 summarizes the expression profiles of the differentially regulated proteins,
and the fold expression values represent themean expression of the proteins in the islets from
the three donors. Supplemental Table 2 includes the 2log(P value) for the differentially
expressed proteins, the fold differences in the expression, and protein description information
for each individual donor.
Table 1. Differential Protein Expression Between CVB4- vs Mock-Infected Primary Human Islets at 48 hpi
Protein/Gene Fold Difference Protein/Gene Fold Difference
CXB4 ↑8.089 PC ↑1.284
MX1 ↑7.199 SLC25A4 ↑1.284
ISG15 ↑5.817 SLC25A5 ↑1.207
IFIT3 ↑5.138 IDH3B ↑1.185
CXCL1 ↑4.112 MCCC1 ↑1.108
CXCL8 ↑4.014 HIBCH ↑1.078
IFIT1 ↑3.571 SAMHD1 ↑1.066
HIC1 ↑3.484 PPOX ↑1.062
TAP1 ↑3.051 EIF2AK2 ↑1.041
ICAM1 ↑2.833 RBM14 ↓21.020
IFIT2 ↑2.769 UCHL1 ↓21.027
HLA-B ↑2.7624 SEC24C ↓21.132
OAS3 ↑2.390 RAP1GAP2 ↓21.249
TAPBP ↑2.286 PDCD5 ↓21.275
STAT1 ↑2.183 GPD1 ↓21.277
MRPS36 ↑2.146 NACA ↓21.312
HLA-C ↑1.840 PCP4 ↓21.338
DDX58 ↑1.830 GHRL ↓21.404
TYMP ↑1.793 PLCXD3 ↓21.421
PML ↑1.651 VAT1L ↓21.463
LGALS9 ↑1.625 RPL27 ↓21.503
GBP1 ↑1.563 PRSS2 ↓21.689
HLA-A ↑1.477 PPP1R1A ↓21.752
EHD4 ↑1.417 UBQLN2 ↓21.891
WARS ↑1.379 ATP6AP1 ↓21.970
APOL2 ↑1.378 INS ↓22.152
LAP3 ↑1.337 WIBG ↓22.315
COX7C ↑1.312 REG3A ↓23.103
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We evaluated the molecular processes/functions and disease processes modulated in
primary human islets following CVB4 challenge vs mock infection by analyzing differentially
expressed proteins using IPA. The Top Canonical Pathways, TopDiseases and Bio Functions,
Molecular and Cellular Functions, and Physiological System Development and Function
predicted for the proteins/genes that are differentially regulated in CVB4-infected islets and
their respective probability values are summarized in Table 2.
Many of the significantly upregulated proteins participate in the host antiviral response, as
anticipated, and have been shown by others to be induced at the level of gene expression in
cultured human islets challenged with enteroviruses [8, 13, 14]. MX1/MxA, which is more
than sevenfold upregulated in CVB4-infected islets compared with mock-infected islets,
possesses broad antiviral activity. The ubiquitin-like protein ISG15 plays a critical role in the
innate immune response to viral infection. Multiple additional IFN-induced antiviral RNA-
binding proteins, including IFIT1, IFIT2, IFIT3, STAT1, and OAS3, are upregulated in
CVB4-infected islets. TAP1, also known as antigen peptide transporter 1, is 3.5-fold upre-
gulated in CVB4-infected cells vs controls. TAP1 is involved in the transport of antigens from
the cytoplasm to the endoplasmic reticulum (ER) for association with major histocompati-
bility complex (MHC) class I molecules and acts as a molecular scaffold for the final stage of
MHC class I folding by binding with the peptides [22]. TAPBP (tapasin) was also upregulated
and is involved in the association ofMHC class I with TAP1 and in the assembly of MHC class
I with peptide [23]. Other genes/proteins involved in antigen presentation, including HLA-A,
-B, and -C, were also increased.
The most significantly downregulated proteins in the CVB4-infected islets are regener-
ating islet-derived protein 3-a (REG3A), WIBG, and INS. The decrease in INS is consistent
with our previous finding of decreased INS at the transcriptional level following CVB4 in-
fection of human islets [18] and is in agreement with findings that intracellular insulin levels
decrease in CVB-infected human pancreatic cultures [24].
We performed regulator effects analysis using IPA to elucidate the causes and effects of
differentially expressed proteins upon infection of islets. “Regulator Effects” explains how
predicted activated or inhibited upstream regulators might cause increases or decreases in
phenotypic or functional outcomes downstream. These causal hypotheses take the form of
directionally coherent networks formed from the merger of Upstream Regulator networks
with Downstream Effects networks [25]. IPA was used to investigate the regulation of the top
networks associated with the profile of differentially expressed proteins obtained from
quantitative proteomic analyses. Table 2 also summarizes the top five regulator effect
networks and their associated networks, the corresponding diseases and functions, and
respective scores obtained from IPA. The consistency score is a measurement used to rank or
prioritize themost useful networks. The protein networkwith the highest consistency score of
33.5 includes BTK, EIF2AK2, IFNA2, IFNG, IFNL1, PRL, SOCS1, TLR7, and TLR9, which
are all involved in autoimmunity. The associated activated networks are relapsing-remitting
multiple sclerosis, which is predicted to be activated, and the replication of virus replicon,
which is inhibited (Fig. 1). The top network corresponds to pathways related to antimicrobial
response, inflammatory response, and infectious diseases (significance score of 40) (Fig. 2).
The central molecule node of the network upregulated in CVB4-infected islets is STAT1. The
top network analysis includes the following proteins, all of which were significantly upre-
gulated: HLA-A, HLA-B, HLA-C, TAP1, TAP, ICAM, OAS3, SAMHD1, ISG, PML, DDX58,
and GBP1. The other nodes in the network include the nuclear factor kB complex, a master
regulator of the immune response, P38 mitogen-activated protein kinase (MAPK), and the
phosphatidylinositol 3-kinase complex.
B. CVB4 Infection Modulates Gene Expression in Cultured Human Islets
To correlate potential changes in gene expression with our proteomics analyses, we examined
islet RNA expression over a time course using a NanoString platform. Cultured islets were
independently studied from four different human donors, including donors used in the
1276 | Journal of the Endocrine Society | doi: 10.1210/js.2017-00278
Table 2. Summary of IPA of CVB4-Infected Islets vs Mock-Infected Islets
Top canonical pathways
Name P value Overlap
Interferon signaling 7.45E-10 16.7% (6/36)
Antigen presentation pathways 7.35E-08 13.2% (5/38)
T1D signaling 1.28E-05 4.7% (5/106)
Activation of IRF by cytosolic PRRs 2.57E-05 6.7% (4/60)
Th1 pathway 3.44E-05 3.8% (5/130)
Top upstream regulators
Upstream regulator P value of overlap Predicted activation
IFNG 1.12E-22 Activated
IFNL1 6.98E-22 Activated
MAPK1 9.78E-19 Inhibited
IFNA2 4.17E-16 Activated
IFNB1 3.95E-14 Activated
Top diseases and bio functions
Diseases and disorders
Name P value Number of molecules
Antimicrobial response 2.85E-03–4.91E-12 11
Inflammatory disease 2.19E-02–4.91E-12 28
Dermatological diseases and conditions 1.14E-02–2.04E-09 21
Organismal injury and abnormalities 2.19E-02–2.04E-09 53
Immunological disease 2.18E-02–1.79E-08 32
Molecular and cellular functions
Name P value Number of molecules
Cell signaling 1.08E-02–2.20E-07 14
Cell death and survival 2.13E-02–3.53E-07 23
Cellular growth and proliferation 1.98E-02–1.05E-06 26
Cellular movement 2.25E-02–2.94E-05 17
Carbohydrate metabolism 1.70E-02–3.26E-05 4
Physiological system development and function
Name P value Number of molecules
Cardiovascular system development and
function
1.85E-02–2.17E-05 10
Organismal development 1.85E-02–2.17E-05 12
Tissue development 1.85E-02–6.40E-05 10
Tissue morphology 1.98E-02–6.92E-03 7
Hematological system development and
function
1.98E-02–1.21E-04 11
Top regulator effect networks
ID regulators Diseases and functions Consistency score
BTK, EIF2AK2, IFNA2, IFNG, IFNL1, PRL,
SOCS1, TLR7, TLR9
Relapsing-remitting multiple
sclerosis and replication
of virus replicon
33.5
JAK1, NLRC5, TGM2 Viral infection 2.774
MAPK1 Viral infection 21.664
IFNA2 Cell death 22.333
IL1RN Cell death 22.828
Top networks
ID-associated network functions Score
Antimicrobial response, inflammatory response,
infectious diseases
40
Cellular growth and proliferation, development,
cellular development, and lymphoid tissue
structure
14
Cell signaling, cancer, organismal injury, and
abnormalities
8
Developmental disorder, hereditary disorder,
metabolic disease
2
Cellular assembly and organization,
gastrointestinal disease, and hepatic
system disease
2
Abbreviations: IRF, IFN-regulatory factor; PRR, pattern recognition receptor; Th1, T helper 1.
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proteomics study (Supplemental Table 1). Cytotoxicitywas examined and infectionmonitored
(Supplemental Fig. 1). We focused on genes with at least a twofold change with CVB4 in-
fection or poly I:C treatment compared with mock treatment. We clustered the expression
pattern using a k-means clustering algorithm. In the heatmap of Fig. 3, clusters 1 and 2 (dark
blue and light blue) contain genes induced upon treatment, including inflammatory response
genes and ISGs, whereas cluster 4 (light maroon) contains genes downregulated, such as INS
and PDX1; GCG is unaffected by CVB4 infection, consistent with our previous report [18].
Type I IFN genes are among the first to increase in expression following CVB4 infection.
IFNL3 gene expression is induced, consistent with recent studies on CVB triggering primary
human islets to produce type III IFN [9]. CVB gene expression is sustained over the time
course (Fig. 3, bottom panel).
Figure 1. IPA Top Regulator Effect with the highest consistent score of 33.5 (Table 2)
showing inhibited and activated diseases and functions and the associated molecules.
Proteins shown in orange are activated, whereas those in blue are inhibited in the CVB4-
infected islets. Orange dashed lines depict activation, whereas blue dashed lines depict
inhibition. The predictions indicate that pathways associated with the “replication of viral
replicon” are inhibited upon CVB4 infection, whereas pathways associated with “relapsing
and remitting multiple sclerosis” (associated with the inflammatory immune response) are
activated. Yellow dashed lines depict findings inconsistent with the state of downstream
molecules. Gray lines show effects not predicted.
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We also challenged cultured human islets with poly I:C, a double-stranded RNA mimetic
and MDA5 agonist, and compared specific gene induction patterns induced by poly I:C vs
CVB4 over time (Fig. 3). Although some genes are induced by both, cluster 3 (gray) includes
genes more robustly induced by CVB4 compared with poly I:C. Conversely, cluster 5 (dark
maroon) includes genesmore robustly induced by poly I:C than by CVB4.We found thatmany
antiviral host responses are induced by poly I:C, particularly at 48 hpi, but unlike for CVB4,
INS gene expression does not decrease with poly I:C challenge, which suggests that CVB4
may specifically influence INS independent from dsRNA signaling and type I IFN induction.
C. EndoC-bH1 Cells Exhibit High Cytotoxicity Following Infection With CVB4
To help define beta cell–specific factors that may affect the development of autoimmune T1D
in the context of viral perturbation, we challenged EndoC-bH1 cells with CVB4. EndoC-bH1
cells exhibit considerable cytotoxicity by 48 hpi following infection with CVB4 (MOI of 1)
(Supplemental Fig. 2A). To visualize viral protein and insulin, CVB4-infected (MOI of 10)
EndoC-bH1 cells at 6 hpi were stained with anti-VP1– (green) and anti-insulin–specific (red)
antibodies. VP1 was readily detected, and colocalization with insulin was present (yellow)
(Supplemental Fig. 2B). Although EndoC-bH1 cells that appear to have escaped infection
display a similar staining intensity for insulin as mock-treated cells, from image analysis
alone, it is unclear if individual CVB4-infected cells have reduced insulin compared with
uninfected (VP1-negative) cells (Supplemental Fig. 2C). Challenge with CVB4 (MOI of 10)
resulted in 62% of VP1-positive cells at 6 hpi. CVB4-infected EndoC-bH1 cells have a similar
Figure 2. IPA Top Network generated from differentially regulated proteins between
CVB4- and mock-infected primary human islets. Proteins shown in color are significantly
differentially expressed based on the statistical analysis (red, upregulated; green,
downregulated). A solid line represents a direct interaction between the two gene products,
and a dotted line represents an indirect interaction. STAT1 is significantly upregulated and
is one of the central nodes in the network.
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proportion of dead cells compared with mock-treated cultures at 6 hpi. By 24 hpi, 29% of cells
were VP1 positive (Supplemental Fig. 2D), and 74% dead cells were observed (Supplemental
Fig. 2E).
D. Gene Expression and Proteomics Were Evaluated in CVB4-Infected EndoC-bH1 Cells
To compare the gene expression effects of CVB4 infection between human islets and EndoC-
bH1 cells, we performed three independent EndoC-bH1 infections using CVB4 (MOI of 10).
Gene expression was assessed at 6 and 24 hpi using the same NanoString CodeSet as for the
primary human islets. We performed similar clustering as for human islets and observed
robust gene induction at 24 hpi, particularly for ISGs (Fig. 4). INS gene expression was
decreased in CVB4-challenged cells compared with mock-treated cells at 24 hpi. CVB gene
expression increased by 10-fold between 6 and 24 hpi, indicative of viral replication (Fig. 4,
bottompanel). The gene expression data of CVB4-infectedEndoC-bH1 cells recapitulate some
features observed in human islets infected with CVB4 and confirm that human beta cells are
indeed capable of antiviral responses following infection. Of note, we processed EndoC-bH1
Figure 3. Gene expression in cultured primary human islets following challenge with CVB4
or poly I:C. The heat map depicts the five clusters of genes that have at least twofold change
compared with mock in the average of the four replicates. The color bar highlights five
clusters obtained after k-means clustering. Genes in boldface are also found in Table 1.
Averages for four independent human donors were used. Time points are indicated. Average
CVB copies per condition, measured by NanoString, are shown in the bottom panel; error
bars represent the standard deviation.
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Figure 4. Gene expression in EndoC-bH1 cells following challenge with CVB4 (MOI of 10)
compared with mock. The heat map shows five clusters obtained after k-means clustering of
genes having at least a twofold change with CVB4 compared with mock. Clusters 1, 3, 4, and
5 have genes induced with CVB4. Cluster 2 (light blue) has genes downregulated with CVB4,
including INS. Averages for three independent experiments were used. Time points are
indicated. Average CVB copies per condition, measured by NanoString, are shown in the
bottom panel; error bars represent the standard deviation.
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cells for proteomics analysis following infection with CVB4 (MOI of 5) at 24 hpi in two in-
dependent experiments. However, infected samples revealed no increases in either viral
proteins or proteins expected to be induced based on gene expression data, presumably due to
excessive cell death (data not shown).
3. Discussion
Understanding amechanistic role of enteroviral infection in T1D is a priority. The role of virus
infection in the setting of autoimmunity is still under investigation, but it has become in-
creasingly clear that an islet insult leading to local inflammation is likely central in initiating
the autoimmune process. Using a proteomics approach, we identified host factors modulated
during acute CVB4 infection that could prove useful in identifying individuals at risk for
progressing to T1D as well as therapeutic targets for prevention and intervention. We found
that the insulin level is decreased in human islets following viral challenge and characterized
themodulation of islet proteins not previously reported to be associatedwith viruses andT1D.
Beta cell death following CVB4 infection likely contributes to some of the observed decreases
in insulin [5] and will be important to quantify in future studies.
We confirmed the upregulation of several antiviral response factors includingMxA, ISG15,
andHLA class I antigens, as discussed above. HIC1 (hypermethylated in cancer 1 protein) is a
transcriptional repressor that is upregulated in CVB4-infected human islets. HIC1 down-
regulates SIRT1, a protein involved in regulating p53/TP53-dependent apoptotic DNA-
damage responses [26]. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct
target of HIC1 [27]. CXCR7 and other chemokine receptors are suggested to be T1D de-
terminants, especially in autoimmunity and beta cell destruction [28]. HIC1 has also been
demonstrated to modulate transcriptional stimulation of the genes regulated by canonical
Wnt/beta-catenin signaling [29].
A high correlation between the protein and gene expression is observed between MS and
gene expression analyses using protein and RNA, respectively, extracted from islets. The
proteins/genes significantly modulated in both analyses include MX1, ISG15, CXCL8, IFIT1,
IFIT2, STAT1, DDX58, HLA-A (all increased), and INS (decreased). Furthermore, many of
the proteins increased in our study reportedly have significantly increased transcripts at
48 hpi byRNA-Seq in primary cultured human islets challengedwithCVB3 strainNancy [14].
These include APOL2, DDX58, EIF2AK2, GBP1, IFIT1, IFIT2, IFIT3, ISG15, LAP3, MX1,
OAS3, PML, SAMHD1, STAT1, TAP1, TYMP, andWARS or ~10% of the genes reported to be
increased [14]. Differences in the expression profiles of proteins and RNA transcripts in the
CVB4-infected islets can be partially explained by molecular events such as translational
efficiency, alternative splicing, trafficking and localization, posttranslational modifications,
secretion, and proteolytic degradation, all of which affect protein abundance independently of
transcripts. Discrepancies could be explained further by human islet donor variability and
differences in viral serotypes used, as CVB3 Nancy and CVB4 JVB are ~80% identical by
nucleotide sequence. Regardless, the orthogonal validation of differential expression of the
genes using independent but complementary technologies validate the robustness of our data.
A number of proteins besides insulin were downregulated in CVB4-infected islets com-
pared with control. Following CVB4 challenge, REG3A was the most significantly decreased.
REG3A contains a peptide that may stimulate islet neogenesis and insulin production [30,
31], and its downmodulation following islet infection is reported in this study, although,
interestingly, we previously described its upregulation in pancreata from autoantibody-
positive subjects [32]. Decreased WIBG expression was also observed. The significance of
this downregulation is unknown; however, a critical regulator of the exon junction complex,
WIBG is postulated to bind to RNA and may be involved in positive regulation of translation
[33]. ATP6AP1 (V-type proton ATPase subunit S1) is a vacuolar ATPase belonging to a family
of proteins responsible for acidifying a variety of intracellular compartments in eukaryotic
cells. Its downregulation (21.970) may correlate with the observed decrease in INS because it
is predicted to be involved in insulin receptor recycling [34]. Ubiquilin-2 (UBQLN2), 21.891
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downregulated, is a critical molecule in the regulation of cellular protein degradation
pathways including the ubiquitin-proteasome system, autophagy and the ER-associated
protein degradation pathway [35–38]. The downregulation (21.752) of protein phospha-
tase 1 regulatory subunit 1A (PPP1R1A) correlates with previous reports proposing that the
protein is a real-time biomarker of beta cell destruction [39]. Downregulation of PRSS2
(trypsin-2), a trypsinogen,may reflect acinar cell presence in the islet preparations; given that
human acinar cells are not typically infected by CVB4, this may occur secondary to changes in
the local culture environment.
Many proteins modulated in CVB4-infected islets were reported in proteomic analysis of
islets from individuals with enterovirus-associated fulminant diabetes [40], includingWARS,
STAT1, HLA-C, TYMP, APOL2, and SAMHD1. WARS, also known as tryptophan–transfer
RNA ligase, has been linked to the regulation of angiogenesis and distinct cytokine activities
[41]; like indoleamine 2,3-dioxygenase, it is preferentially induced by IFN-g [42]. STAT1
mediates cellular responses to IFNs, cytokines and other growth factors, andSTAT1 signaling
ultimately activates the transcription of ISGs, which drive the cell to an antiviral state. TYMP
(thymidine phosphorylase) catalyzes the reversible phosphorolysis of thymidine and pos-
sesses angiogenic activity in vivo and chemotactic activity on endothelial cells in vitro [43].
APOL2 binds to high-density lipoproteins and is involved in transportation of lipids, but its
role in the context of enteroviral infection remains unknown. SAMHD1 (deoxynucleoside
triphosphate triphosphohydrolase) is a restriction nuclease that blocks early-stage virus
replication inmyeloid cells [44]. SAMHD1has a protective role in preventing self-activation of
innate immunity, including type I IFN responses, by cell-intrinsic components in Aicardi-
Goutie`res syndrome [45].
The permissiveness of EndoC-bH1 cells to CVB infection enables investigation of the virus-
host relationship within human beta cells and potential identification/characterization of
early biomarkers of viral infection and beta cell function. Indeed, type I IFN stimulation of
EndoC-bH1 cells are reported to increase ER stress markers [46]. Although we observed ISG
induction and downregulation of INS gene expression following infection of these cells, the
impact on insulin secretion at the protein level requires further evaluation. Although high
toxicity confounded proteomics assessment, examination of earlier time points orwith a lower
MOI could be useful for assessing beta cell–specific protein changes following CVB4 infection.
The high cytotoxicity observed in the EndoC-bH1 cells could be due to a lack of a protective
barrier in the islet microenvironment. Alternatively, the cells may lack survival signals from
surrounding cell types present in primary islets.
Despite the increasing evidence correlating enterovirus infections with the development of
T1D, establishing a causal relationship remains elusive. In this study, we provide additional
insight on how enteroviruses may suppress human beta cells and identify potential markers for
the initiation and progression of T1D. Although we used a standard sample size for our MS
analyses, some proteins of potential interest did not meet the criteria for statistical significance
that perhaps would have been identified with a larger sample size (i.e., our studywas limited by
low power). Nevertheless, our current studies confirm the upregulation/activation of specific
molecules and pathways that were previously described in clinical samples of patients with
enterovirus-associated fulminantdiabetes. Thesemolecules are potential therapeutic targets for
intervention againstT1D.Further studies are required to elucidate the role of thesemolecules in
the etiology of T1D and may perhaps be gained through single-cell RNA sequencing of virus-
infected islets, which could further facilitate the development of improved therapeutic or
preventive treatments to halt the development of autoimmunity against beta cells.
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